Intracranial Stenting Doesn’t Make The Cut In NIH Study

Intracranial stenting should not be a first-line treatment in most patients with narrowed brain arteries and a recent neurological event, researchers concluded in a recent study. But the data should not be viewed as a nail in the coffin to future development of intracranial stents, investigators stressed.

More from Archive

More from Medtech Insight